Nota: 0 de 5 estrelas
0 notas
Carregando
author
Peter J. H. Scott
Bio:
Dr. Peter Scott received his B.Sc (with first class honors) in medicinal and pharmaceutical chemistry from Loughborough University, UK in 2001 following research into peptide nucleic acids un...ver maisBio:
Dr. Peter Scott received his B.Sc (with first class honors) in medicinal and pharmaceutical chemistry from Loughborough University, UK in 2001 following research into peptide nucleic acids under the guidance of Prof. Raymond Jones. Upon graduating he pursued doctoral research, designing novel multifunctional linker units for solid-phase synthesis (see Eur. J. Org. Chem., 2006, 2251 - 2268), with Dr. Patrick Steel at the University of Durham, UK and was awarded his Ph.D in 2005. Dr. Scott has also edited one book, “Linker Strategies in Solid-phase Organic Synthesis”, due to be published by John Wiley and Sons in 2009. Following his doctoral work, Dr. Scott moved to the United States to pursue postdoctoral research initially in rhodium carbenoid chemistry at the University of Buffalo with Prof. Huw Davies (2005-2006), and subsequently in radiochemistry and PET imaging with Prof. Michael Kilbourn at the University of Michigan (2006-2007). In 2007 he joined Siemens Molecular Imaging and Biomarker Research where he was head of radiochemistry at the LA Tech Center and involved in the design and synthesis of novel radiopharmaceuticals for use in PET imaging. Dr. Scott returned to the University of Michigan School of Medicine in 2009 after being appointed to the faculty of the Department of Radiology. His research interests are at the interface between nuclear medicine and organic chemistry and focus upon the adaptation of state-of-the-art organic chemistry techniques (including SPOS) for radiochemical applications, including the simplified synthesis of novel radiopharmaceuticals and multi-modality (e.g. PET-MRI, PET-CT) molecular probes.ver menos